297 related articles for article (PubMed ID: 19698894)
1. Chapter 1. Regulation of HIV-1 alternative RNA splicing and its role in virus replication.
Stoltzfus CM
Adv Virus Res; 2009; 74():1-40. PubMed ID: 19698894
[TBL] [Abstract][Full Text] [Related]
2. A suboptimal 5' splice site downstream of HIV-1 splice site A1 is required for unspliced viral mRNA accumulation and efficient virus replication.
Madsen JM; Stoltzfus CM
Retrovirology; 2006 Feb; 3():10. PubMed ID: 16457729
[TBL] [Abstract][Full Text] [Related]
3. Two strong 5' splice sites and competing, suboptimal 3' splice sites involved in alternative splicing of human immunodeficiency virus type 1 RNA.
O'Reilly MM; McNally MT; Beemon KL
Virology; 1995 Nov; 213(2):373-85. PubMed ID: 7491762
[TBL] [Abstract][Full Text] [Related]
4. Role of viral splicing elements and cellular RNA binding proteins in regulation of HIV-1 alternative RNA splicing.
Stoltzfus CM; Madsen JM
Curr HIV Res; 2006 Jan; 4(1):43-55. PubMed ID: 16454710
[TBL] [Abstract][Full Text] [Related]
5. Negative and positive mRNA splicing elements act competitively to regulate human immunodeficiency virus type 1 vif gene expression.
Exline CM; Feng Z; Stoltzfus CM
J Virol; 2008 Apr; 82(8):3921-31. PubMed ID: 18272582
[TBL] [Abstract][Full Text] [Related]
6. Synergistic stimulation of HIV-1 rev-dependent export of unspliced mRNA to the cytoplasm by hnRNP A1.
Najera I; Krieg M; Karn J
J Mol Biol; 1999 Feb; 285(5):1951-64. PubMed ID: 9925777
[TBL] [Abstract][Full Text] [Related]
7. The strength of the HIV-1 3' splice sites affects Rev function.
Kammler S; Otte M; Hauber I; Kjems J; Hauber J; Schaal H
Retrovirology; 2006 Dec; 3():89. PubMed ID: 17144911
[TBL] [Abstract][Full Text] [Related]
8. An exonic splicing silencer downstream of the 3' splice site A2 is required for efficient human immunodeficiency virus type 1 replication.
Madsen JM; Stoltzfus CM
J Virol; 2005 Aug; 79(16):10478-86. PubMed ID: 16051840
[TBL] [Abstract][Full Text] [Related]
9. Identification of alternative splicing and negative splicing activity of a nonsegmented negative-strand RNA virus, Borna disease virus.
Tomonaga K; Kobayashi T; Lee BJ; Watanabe M; Kamitani W; Ikuta K
Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12788-93. PubMed ID: 11070091
[TBL] [Abstract][Full Text] [Related]
10. Influence of the small leader exons 2 and 3 on human immunodeficiency virus type 1 gene expression.
Krummheuer J; Lenz C; Kammler S; Scheid A; Schaal H
Virology; 2001 Aug; 286(2):276-89. PubMed ID: 11485396
[TBL] [Abstract][Full Text] [Related]
11. The HIV-1 rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA.
Malim MH; Hauber J; Le SY; Maizel JV; Cullen BR
Nature; 1989 Mar; 338(6212):254-7. PubMed ID: 2784194
[TBL] [Abstract][Full Text] [Related]
12. Alternative splicing: regulation of HIV-1 multiplication as a target for therapeutic action.
Tazi J; Bakkour N; Marchand V; Ayadi L; Aboufirassi A; Branlant C
FEBS J; 2010 Feb; 277(4):867-76. PubMed ID: 20082634
[TBL] [Abstract][Full Text] [Related]
13. Inclusion of the NS2-specific exon in minute virus of mice mRNA is facilitated by an intronic splicing enhancer that affects definition of the downstream small intron.
Haut DD; Pintel DJ
Virology; 1999 May; 258(1):84-94. PubMed ID: 10329570
[TBL] [Abstract][Full Text] [Related]
14. In silico mutagenesis of RNA splicing in HIV-1.
Kim H; Yin J
Biotechnol Bioeng; 2005 Sep; 91(7):877-93. PubMed ID: 15937951
[TBL] [Abstract][Full Text] [Related]
15. Dual effect of the SR proteins ASF/SF2, SC35 and 9G8 on HIV-1 RNA splicing and virion production.
Jacquenet S; Decimo D; Muriaux D; Darlix JL
Retrovirology; 2005 May; 2():33. PubMed ID: 15907217
[TBL] [Abstract][Full Text] [Related]
16. Presence of exon splicing silencers within human immunodeficiency virus type 1 tat exon 2 and tat-rev exon 3: evidence for inhibition mediated by cellular factors.
Amendt BA; Si ZH; Stoltzfus CM
Mol Cell Biol; 1995 Aug; 15(8):4606-15. PubMed ID: 7623852
[TBL] [Abstract][Full Text] [Related]
17. Biological importance and cooperativity of HIV-1 regulatory gene splice acceptors.
Riggs NL; Little SJ; Richman DD; Guatelli JC
Virology; 1994 Jul; 202(1):264-71. PubMed ID: 8009838
[TBL] [Abstract][Full Text] [Related]
18. Use of minigene systems to dissect alternative splicing elements.
Cooper TA
Methods; 2005 Dec; 37(4):331-40. PubMed ID: 16314262
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of intronic and exonic locations of the human immunodeficiency virus type 1 Rev-responsive element.
Campbell LH; Borg KT; Arrigo SJ
Virology; 1996 May; 219(2):423-31. PubMed ID: 8638408
[TBL] [Abstract][Full Text] [Related]
20. Solution structure of the HIV-1 exon splicing silencer 3.
Levengood JD; Rollins C; Mishler CH; Johnson CA; Miner G; Rajan P; Znosko BM; Tolbert BS
J Mol Biol; 2012 Jan; 415(4):680-98. PubMed ID: 22154809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
